Skip to content

Comparison of bioactive glass S53P4 as bone graft substitute and autologous bone graft in the treatment of chronic osteomyelitis and infected non-unions – a comparative retrospective study

Comparison of bioactive glass S53P4 as bone graft substitute and autologous bone graft in the treatment of chronic osteomyelitis and infected non-unions – a comparative retrospective study - Bioactive glass versus autologous bone graft in osteomyelitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00014049
Enrollment
100
Registered
2018-02-26
Start date
2018-03-02
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M86.6

Interventions

Group 1: Retrospective analysis of bony defect filling with bioactive glass S53P4 in patients with chronic osteomyelitis and/ or infected non-unions between 07/2013 and 01/2017 Group 2: Retrospective

Sponsors

BG Klinikum Duisburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Chronic osteomyelitis and/ or infected non-union - Filling of the bony defect with either autologous bone graft or bioactive glass S53P4 - Follow-up at a minimum of 12 months

Exclusion criteria

Exclusion criteria: - Aseptic non-union - Follow-up < 12 months

Design outcomes

Primary

MeasureTime frame
Permanent control of infection during follow-up (date of filling the defect – max. 01/2018) All findings of the consultation hours – independent of this study – are evaluated

Secondary

MeasureTime frame
- Bony fusion, respectively incorporation of the bioactive glass - Full weight bearing - Complications due to bioactive glass, respectively the extraction of autologous bone graft - Complications All findings of the consultation hours – independent of this study – are evaluated

Countries

Germany

Contacts

Public ContactEva Steinhausen

BG Klinikum Duisburg

evasimone.steinhausen@bg-klinikum-duisburg.de+49 203 7688 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026